CNS/Neurodegeneration Transporter Assay
The study of central nervous system (CNS) disorders and neurodegeneration is of paramount importance in the field of neuroscience. Researchers and pharmaceutical companies are constantly striving to develop novel therapeutics to combat these debilitating conditions. To accelerate drug discovery and gain a deeper understanding of disease mechanisms, reliable and efficient transporter assays are essential. Creative Biolabs, a leading company in the field of biomedical research, offers state-of-the-art CNS/Neurodegeneration Transporter Assays to support the scientific community in their quest for new treatments and insights.
Transport Assays: Unlocking the Secrets of Cellular Transport
Dysfunction or dysregulation of transporters proteins has been implicated in a wide range of neurological disorders, including Alzheimer's disease, Parkinson's disease, and depression. Transport assays provide a valuable tool for evaluating the activity and specificity of these transporter proteins.
At Creative Biolabs, we offer a comprehensive evaluation of transporter proteins. This assay system allows for the quantification of transporter activity, determination of substrate specificity, and assessment of the effect of potential drug candidates on transporter function.
Assays:
- Uptake transporter assays
- Efflux transporter assays
- Substrate binding assays
- Inhibition screening
- Radioactive flux detection
- Fluorescence detection
- Electrophysiology assay
- Vesicular transport assay
Features
Functional Characterization
Cell-based assays offer the ability to assess the functional effects of compounds on cellular systems, providing valuable insights into their activity and mechanism of action.
Coverage of Key Transporters
These assays can evaluate the interaction of compounds with key transporters, such as efflux pumps. or uptake transporters, which play a crucial role in drug disposition and pharmacokinetics.
Availability of Various Panels
Cell-based assays provide the flexibility to choose from a variety of panels, including specific cell lines or tissues, to mimic the relevant biological context and assess compound activity in a more targeted manner.
Customized Screening Project
Cell-based assays can be tailored to meet specific project requirements, enabling the design of customized screening strategies to address unique research questions or target specific pathways or cellular processes.
Monoamine Transporter Panel: Shedding Light on Neurotransmitter Imbalances
The Monoamine Transporter Panel can be tailored to specific requirements, enabling the investigation of specific transporters such as the serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET). By studying the interaction between drug candidates and these transporters, researchers can assess the potential therapeutic benefits and risks associated with their compounds.
Transporter | Gene | Species | Cell Model | Probe Substrate | Reference Positive Control |
SERT | SLC6A4 | Human | MDCK-II/HEK293 | [3H]Serotonin | Fluoxetine |
NET | SLC6A2 | Human | MDCK-II/HEK293 | [3H] norepinephrine | Desiparmine |
DAT | SLC6A3 | Human | MDCK-II/HEK293 | [3H]Dopamine | Nomifensine |
Drug Transporters Panel: Assessing Pharmacokinetic Properties
Pharmacokinetic properties play a crucial role in determining the efficacy and safety of drug candidates. Creative Biolabs' Drug Transporters Panel offers a comprehensive evaluation of drug transporters involved in the absorption, distribution, metabolism, and excretion (ADME) of therapeutic compounds. This full panel includes seven (7) FDA transporters panel such as P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and organic anion-transporting polypeptides (OATPs).
Transporter | Gene | Species | Cell Model | Probe Substrate | Reference Positive Control |
BCRP | ABCG2 | Human | MDCK-II | [3H]-estrone-3-sulfate | chrysin |
OAT1 | SLC22A6 | Human | MDCK-II | [3H]-p-aminohippurate | probenecid |
OAT3 | SLC22A8 | Human | MDCK-II | [3H]-estrone-3-sulfate | probenecid |
OATP1B1 | SLCO1B1 | Human | MDCK-II | [3H]-estrone-3-sulfate | rifampicin |
OATP1B3 | SLCO1B3 | Human | MDCK-II | [3H]-estrone-3-sulfate | rifampicin |
OCT2 | SLC22A2 | Human | MDCK-II | [3H]-MPP+ | quinidine |
P-gp(MDR1) | ABCB1 | Human | MDCK-II | [3H]-digoxin | verapamil |
Other Transporters: Unveiling Novel Targets and Mechanisms
In addition to monoamine and drug transporters, Creative Biolabs' CNS/Neurodegeneration Transporter Assays encompass a wide range of other transporters associated with CNS disorders and neurodegeneration. These include glutamate transporters, GABA transporters, amino acid transporters, and ATP-binding cassette (ABC) transporters.
Transporter | Gene | Species | Cell Model | Probe Substrate | Reference Positive Control |
OAT4 | SLC22A11 | Human | MDCK-II | Estrone-3-sulfate | Indomethacin |
OAT3 | SLC22A8 | Human | MDCK-II | Estrone-3-sulfate | Probenecid |
OAT2 | SLC22A7 | Human | MDCK-II | cGMP | Indomethacin |
OAT1 | SLC22A6 | Human | MDCK-II | p-Aminohippurate | Probenecid |
NTCP | SLC10A1 | Human | MDCK-II | Taurocholate | NaCDC |
NET | SLC6A2 | Human | MDCK-II | Dopamine | Desipramine |
MRP4 | ABCC4 | Human | Vesicle | Estradiol-17-ß-D-glucuronide | Benzbromarone |
MRP3 | ABCC3 | Human | Vesicle | Estradiol-17-ß-D-glucuronide | Benzbromarone |
MRP2 | ABCC2 | Human | Vesicle | Estradiol-17-ß-D-glucuronide | Benzbromarone |
MRP1 | ABCC1 | Human | Vesicle | Estradiol-17-ß-D-glucuronide | Benzbromarone |
MCT1 | SLC16A1 | Human | MDCK-II | 2-Thiophene-glyoxylic acid | Phloretin |
MATE2-K | SLC47A2 | Human | MDCK-II | Metformin | Cimetidine |
MATE1 | SLC47A1 | Human | MDCK-II | Metformin | Cimetidine |
LAT1 | SLC7A5 | Human | MDCK-II | Leucine | JPH203 |
GLYT2 | SLC6A5 | Human | MDCK-II | Glycine | Org25543 |
GLYT1 | SLC6A9 | Human | MDCK-II | Glycine | Sarcosine |
GAT3 | SLC6A11 | Human | MDCK-II | GABA | Nipecotic acid |
GAT2 | SLC6A13 | Human | MDCK-II | GABA | Nipecotic acid |
GAT1 | SLC6A1 | Human | MDCK-II | GABA | Nipecotic acid |
ENT4/PMAT | SLC29A4 | Human | MDCK-II | Metformin | Decynium-22 |
ENT2 | SLC29A2 | Human | MDCK-II | Hypoxanthine | Adenosine |
ENT1 | SCL29A1 | Human | MDCK-II | Adenosine | NBMPR |
EAAT3 | SLC1A1 | Human | MDCK-II | Glutamic acid | Way-213613 |
EAAT2 | SLC1A2 | Human | MDCK-II | Glutamic acid | Cysteic acid |
EAAT1 | SLC1A3 | Human | MDCK-II | Glutamic acid | Cysteic acid |
DAT | SLC6A3 | Human | MDCK-II | Dopamine | Venlafaxine |
CRT | SLC6A8 | Human | MDCK-II | Creatine | 3-Guanidinopropionic acid |
CNT3 | SLC28A3 | Human | MDCK-II | Uridine | Adenosine |
CNT2 | SLC28A2 | Human | MDCK-II | Uridine | Adenosine |
CNT1 | SLC28A1 | Human | MDCK-II | Uridine | Adenosine |
CHT | SLC5A7 | Human | MDCK-II | Choline | |
CAT3 | SLC7A3 | Human | MDCK-II | Arginine | Lysine |
CAT2B | SLC7A2 | Human | MDCK-II | Arginine | |
CAT1 | SLC7A1 | Human | MDCK-II | Arginine | Lysine |
BSEP | ABCB11 | Human | Vesicle | Taurocholate | Rifampicin |
BAT1 | SLC7A9 | Human | MDCK-II | Proline | |
ATB0+ | SLC6A14 | Human | MDCK-II | Leucine | N-Ethylmaleimide |
ASCT2 | SLC1A5 | Human | MDCK-II | Glutamine | Alanine |
asc-1 | SLC7A10 | Human | MDCK-II | Glycine | Serine |
ASBT | SLC10A2 | Human | MDCK-II | Taurocholate | NaCDC |
Creative Biolabs offers an extensive collection of transporters, encompassing a wide range of major families. For a comprehensive list of functionally validated transporters, please feel free to contact us for more information.
- NeuroMab™ Anti-Alpha Synuclein Antibody(NRP-0422-P614) (Cat#: NRP-0422-P614)
- NeuroMab™ Anti-CD32b Antibody(NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- NeuroMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Anti-Alpha Synuclein BBB Shuttle Antibody(NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- NeuroMab™ Anti-F-Spondin/SPON1 Antibody, Clone N24875P (CBP11839) (Cat#: NRZP-0822-ZP4740)
- NeuroMab™ Anti-FGFR1 Antibody(NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Green Fluorescent Alpha-synuclein SH-SY5Y Cell Line (Cat#: NCL2110P209)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Rat Muller Cell (Cat#: NCL2110P040)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- pAAV-EF1a-DIO-EGFP-WPRE (Cat#: NTA-2012AD-P285)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- rAAV-CAG-DIO-G-Flamp1 (Cat#: NRZP-0722-ZP719)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- AAV-EF1a-mCherry-flex-dtA (Cat#: NRZP-0622-ZP616)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)